Latest Breaking News On - Cell based therapy - Page 1 : comparemela.com

Logiq, Inc Signs Letter of Intent to Acquire Privately Held Biotech Company MedLab Essentials, LLC in $100MM Valuation Deal

NEW YORK, NY / ACCESSWIRE / May 23, 2024 / Logiq, Inc. (OTC Markets:LGIQ) ("Logiq" or "the Company"), a pioneering force in digital consumer acquisition solutions, today revealed the signing of a binding

United statesDaniel vinokurBrent suenMedlab bioExchange commissionSecurities exchangeMedlab essentialsLogiq incAcquisition highlightsShareholder interestPortfolio expansionCell therapyUnique positioningCell based therapyTreatment platformGene therapy

Logiq, Inc Signs Letter of Intent to Acquire Privately Held Biotech

Logiq, Inc Signs Letter of Intent to Acquire Privately Held Biotech
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel vinokurBrent suenMedlab bioNews networkSecurities exchangeMedlab essentialsLogiq incAcquisition highlightsShareholder interestPortfolio expansionCell therapyUplisting goalsUnique positioningCell based therapyAdvanced treatment platform

Multiplex immunofluorescence drives translational research

Why building expertise in multiplex immunofluorescence is critical in a translational clinical research setting

City ofUnited kingdomAkoya biosciences phenoimagerTom lundInstitute of cancer researchEditorial articleScientific leadIntegrated pathology unitDigital pathologyCancer researchRoyal marsden hospitalAkoya biosciencesMultiplex immunofluorescence drives translational research selectscienceClinical researchCell based therapyNa imaging

Multiplex immunofluorescence drives translational research

Why building expertise in multiplex immunofluorescence is critical in a translational clinical research setting

City ofUnited kingdomAkoya biosciences phenoimagerTom lundInstitute of cancer researchEditorial articleScientific leadIntegrated pathology unitDigital pathologyCancer researchRoyal marsden hospitalAkoya biosciencesMultiplex immunofluorescence drives translational research selectscienceClinical researchCell based therapyNa imaging

Long-term Survival Data from Longeveron s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association – IT Business Net

Long-term Survival Data from Longeveron s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesSunjay kaushalMike moyerDrug administrationBlood instituteLongeveron incNational heartCompany quarterlyScientific sessions of the american heart associationLongeveron or companyNational institute of health heartExchange commissionExtended follow up data show continuedTransplant free survivalSupport continued investigationAging related frailty